Global Microfluidics Market Size, Market Share, Application Analysis

Applications of microfluidics in drug delivery and diagnostics will continue to fuel the market for microfluidics over the next few years.

"The US$ 2.9 Bn microfluidics market will possibly cross US$ 11 Bn by the end of 2026.

The collective share of North America and Asia Pacific will be over 40%," states Future Market Insights in a recently published market report outlook, titled "Microfluidics Market: Global Industry Analysis and Opportunity Assessment, 2016-2026.

The market is likely to witness a robust CAGR of 14.4% over the assessed period.Request a Sample Report with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-398Key Insights: Market Dynamics  Increasing discretionary funding from national labs for R in the developed regions will remain a primary factor driving the growth of market through 2026.Improving healthcare infrastructure and wide availability of affordable microfluidic devices or kits are also foreseen to boost the market growth in near future, especially in developing countries.Expansion of drug delivery sector will favour the market growth in near future.Consistent advancements in the fields of genomics and proteomics are also expected to benefit the sales of microfluidics-based devices and kits.Dynamic collaborations between key market players and active involvement of government entities will collectively foster the market through 2026.Key Insights: Segments Ceramics will remain dominant material type Based on material, ceramics will continue to be the most sought after material for microfluidic device or kit manufacturing.

While ceramics is likely to witness the fastest growth, polymer segment is anticipated to exhibit a significant CAGR of over 15% over 2016-2026, driven by PVC.Preview Analysis on Global Microfluidics Market Segmentation By Material Type - Polymer (Polyvinyl chloride (PVC), Non-polyvinyl chloride), Glass, Silicon, Metal, Ceramics; By Application Type - Point of care testing, Clinical Diagnostics, Drug Delivery, Analytical Testing (Genomics, Proteomics, Cell Based Analysis); By Industry - Pharmaceuticals, In-vitro Diagnostics, Environmental Research, Life Science Research, Clinical DiagnosticsPOCT will be dominant application segment By application, POCT (point of care testing) segment is projected to retain dominance through 2026, accounting for over 33% share in terms of revenues.

Clinical diagnostics and analytical testing will remain the next major segments in the global microfluidics market.In-vitro diagnostics industry will hold maximum revenue share  On the basis of industry, in-vitro diagnostics, life science research, and pharmaceuticals are likely to be the key segments.

The Report published on UpMarketResearch.com about “Microfluidics Market” is spread across 133 pages and provides newest industry data, market future trends, allowing you to identify the products and end users driving Revenue growth and profitability.

The industry report lists and studies the leading competitors, also provides the insights with strategic industry Analysis of the key factors influencing the marketMicrofluidics Market Research Report is a professional and in-depth study on the current state which focuses on the major drivers and restraints for the key players.

Microfluidics Industry research report provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.Get FREE Exclusive PDF Sample Copy Of This Report @https://www.upmarketresearch.com/home/requested_sample/4968The report begins with the overview of the Microfluidics market and updates the users about the latest developments and future expectations.

It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.Gain Full Access of Microfluidics Market Report along with complete TOC @https://www.upmarketresearch.com/reports/microfluidics-marketIn this report, there is a healthy amount of coverage of the market economies such as the demand and supply, cost and profit of the Microfluidics Market.

This holds key importance for users and hence this information is well supported with due statistics that are represented in easy to consume graphs, charts, and tables.The report compiles exhaustive information obtained via proven research methodologies and from trusted sources within the industries.

The report segments the Global Microfluidics market as:Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):North AmericaEuropeChinaJapanSoutheast AsiaIndia Key Reasons to Purchase:To gain insightful analyses of the market and have a comprehensive understanding of the Microfluidics and its commercial landscape.Assess the Microfluidics production processes, major issues, and solutions to mitigate the development risk.To understand the most affecting driving and restraining forces in the Microfluidics market and its impact on the global market.Learn about the market strategies that are being adopted by your competitors and leading organizations.To understand the future outlook and prospects for Microfluidics MarketCustomization of the Report:UpMarketResearch provides free customization of reports as per your need.

This microfluidics report provides with the valuable market reports and industry insights so that nothing gets missed by any means.

The report carries out market segmentation is in terms of markets covered, geographic scope, years considered for the study, currency and pricing, research methodology, primary interviews with key opinion leaders, DBMR market position grid, DBMR market challenge matrix, secondary sources, and assumptions.

The report has been generated with the knowledge of skilful and innovative team.Microfluidics market is expected to gain market growth in the forecast period of 2020 to 2027.

Data Bridge Market Research analyses the market to growing at a CAGR of 19.20% in the above-mentioned forecast period.microfluidics market research report has been prepared with the systematic gathering and assessment of market information for microfluidics industry.

Moreover, it highlights both qualitative and quantitative techniques of market analysis where focus groups or in-depth interviews and customer survey or analysis of secondary data has been conducted respectively.

While preparing this microfluidics report, research and analysis has been performed with one step or the combination of several steps depending upon the business and client requirements.

The global microfluidic healthcare industry market is anticipated to rise at a higher CAGR in the forthcoming period.

The report includes Microfluidic for Healthcare Market By Product Type, By Application, By Region Analysis & Forecast 2018-2023.

Advantages offered by use of microfluids include ruggedness, low cost and ability to generate precise results well suited to clinical settings.

• It provides a forward looking perspective on different factors driving or restraining market growth.

• It helps in understanding the key product segments and their future.

• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

The global microfluidics market size is expected to reach USD 31.6 billion by 2027, according to a new report by Radiant Insights, Inc., registering an 11.3% CAGR over the forecast period.

Rise in the adoption of microfluidics for point-of-care diagnostics is expected to have a significant impact on market growth.

Industry players such as Abbott, Roche, and Danaher have already incorporated this technology in their existing diagnostic devices and are exploring the scope of digital microfluidics.

For instance, Philips’ Minicare I-20 handheld device provides accurate and rapid results for the diagnosis of heart attacks.

Large investments targeted toward the development of microfluidics and promoting their adoption are expected to create opportunities for the expansion for automated as well as miniature devices.

Companies such as Abbott, Roche, Cepheid, and Becton, Dickinson and Company (BD) are integrating such technologies with in-vitro diagnostics (IVD).